Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI- supported workflow to optimize quality and response times, initially within prostate. The concept is scalable and can be extended to other diagnoses. 

The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. The report is assisted by our own AI, proven in clinical studies to have world-leading accuracy. The complete workflow is supported by a tailor-made process control system.

The company, based in Sweden, became independent in 2022 through a spin-off from ContextVision, with 40 years of experience within digital imaging for medical applications. It is listed on Euronext Growth Oslo under the ticker INIFY.

Health Diagnostics

Life Sciences

Health Care

Biotechnology

Medical Devices

Inify Laboratories

Fredrik Palm

Ann-Charlotte Linderoth

Magnus Aurell

Claes Lindh

Arto Järvinen

Leadership Team

Sales and Marketing

Technical Development

Teams at Inify Laboratories

Leadership Team

Sales and Marketing

Technical Development